Agency Information Collection Activities; Proposed eCollection, eComments Requested; New Proposed Collection Exempt Chemical Preparations Application, 22070-22071 [2021-08586]
Download as PDF
22070
Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: April 21, 2021.
Lisa Barton,
Secretary to the Commission.
In
accordance with 21 CFR 1301.34(a), this
is notice that on March 15, 2021,
Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Tetrahydrocannabinols ..........
Methylphenidate .....................
Oxycodone .............................
Hydromorphone .....................
Hydrocodone ..........................
Morphine ................................
Opium, Raw ...........................
Oxymorphone ........................
Poppy Straw Concentrate ......
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–827]
Importer of Controlled Substances
Application: Rhodes Technologies
Drug Enforcement
Administration, Department of Justice.
ACTION: Notice of application.
AGENCY:
Rhodes Technologies has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
SUMMARY:
2 All
contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
18:01 Apr 23, 2021
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
Controlled substance
[FR Doc. 2021–08654 Filed 4–23–21; 8:45 am]
VerDate Sep<11>2014
issuance of the proposed registration on
or before May 26, 2021. Such persons
may also file a written request for a
hearing on the application on or before
May 26, 2021.
Jkt 253001
Schedule
7370
1724
9143
9150
9193
9300
9600
9652
9670
I
II
II
II
II
II
II
II
II
The company plans to import Opium,
Raw (9600), and Poppy Straw
Concentrate (9670) in order to bulk
manufacture controlled substances in
Active Pharmaceutical Ingredient (API)
form. The company distributes the
manufactured APIs in bulk to its
customers.
The company plans to import the
other listed controlled substances for
internal reference standards use only.
The comparisons of foreign reference
standards to the company’s
domestically manufactured API will
allow the company to export
domestically manufactured API to
foreign markets.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–08539 Filed 4–23–21; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–NEW]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; New Proposed
Collection Exempt Chemical
Preparations Application
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
AGENCY:
The Drug Enforcement
Administration (DEA), Department of
Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until June
25, 2021.
FOR FURTHER INFORMATION CONTACT: If
you have comments on the estimated
public burden or associated response
time, suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Scott A. Brinks, Diversion Control
Division, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (571) 362–3261.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other forms of
information technology, e.g.,
permitting electronic submission of
responses.
SUMMARY:
E:\FR\FM\26APN1.SGM
26APN1
22071
Federal Register / Vol. 86, No. 78 / Monday, April 26, 2021 / Notices
Overview of This Information
Collection
1. Type of Information Collection:
New collection.
2. Title of the Form/Collection:
Exempt Chemical Preparations
Application.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
N/A. The applicable component within
the Department of Justice is the Drug
Enforcement Administration, Diversion
Control Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public: Business or other forprofit.
Abstract: Pursuant to 21 U.S.C.
811(g)(3)(B), DEA (by delegation of
authority from the Attorney General)
may, by regulation, exempt from
specific provisions of the Controlled
Substances Act (CSA) any compound,
mixture, or preparation containing any
controlled substance, which is not for
administration to a human being or
animal, and which is packaged in a
certain manner, so that as packaged it
Labor category
does not present any significant
potential for abuse. In accordance with
21 CFR 1308.23(f), the Administrator (or
the Deputy Assistant Administrator), at
any time, may revoke or modify any
exemption granted pursuant to 21 CFR
1308.23; modify or revoke the criteria by
which exemptions are granted; and
modify the scope of exemptions.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The below table presents
information regarding the number of
respondents, responses and associated
burden hours.
Number
% of time
Cost
Chemist, GS–14, step 5 ..............................................................................................................
Unit Chief, GS–14, step 5 ...........................................................................................................
Section Chief, GS–15, step 5 ......................................................................................................
3
1
1
30
5
1
$200,967
11,165
2,627
Total ......................................................................................................................................
........................
........................
214,758
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: DEA estimates that
this collection takes 2,093 annual
burden hours.
If additional information is required
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: April 21, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2021–08586 Filed 4–23–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Federal Bureau of Investigation
[OMB Number 1110–0039]
Agency Information Collection
Activities; Proposed eCollection;
eComments Requested; Revision of a
Currently Approved Collection
Bioterrorism Preparedness Act: Entity/
Individual Information
Criminal Justice Information
Services Division, Federal Bureau of
Investigation (FBI), Department of
Justice (DOJ).
ACTION: 30-Day notice.
AGENCY:
The Criminal Justice
Information Services (CJIS) Division,
Federal Bureau of Investigation (FBI),
Department of Justice (DOJ), will be
SUMMARY:
VerDate Sep<11>2014
18:01 Apr 23, 2021
Jkt 253001
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until May 26, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Revision of a currently approved
collection.
(2) Title of the Form/Collection:
Federal Bureau of Investigation
Bioterrorism Preparedness Act: Entity/
Individual Information.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Agency form number: FD–961
Sponsoring component: Criminal Justice
Information Services Division, Federal
Bureau of Investigation (FBI),
Department of Justice (DOJ).
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: City, county, state,
federal, individuals, business or other
for profit, and not-for-profit institute.
This collection is needed to receive
names and other identifying information
submitted by individuals requesting
access to specific agents or toxins, and
consult with appropriate official of the
Department of Health and Human
Services and the Department of
Agriculture as to whether certain
individuals specified in the provisions
should be denied access to or granted
limited access to specific agents.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
E:\FR\FM\26APN1.SGM
26APN1
Agencies
[Federal Register Volume 86, Number 78 (Monday, April 26, 2021)]
[Notices]
[Pages 22070-22071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08586]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-NEW]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; New Proposed Collection Exempt Chemical
Preparations Application
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA), Department of
Justice (DOJ), will be submitting the following information collection
request to the Office of Management and Budget (OMB) for review and
approval in accordance with the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and will be accepted for 60 days until
June 25, 2021.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Scott A. Brinks, Diversion
Control Division, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571)
362-3261.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
[[Page 22071]]
Overview of This Information Collection
1. Type of Information Collection: New collection.
2. Title of the Form/Collection: Exempt Chemical Preparations
Application.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: N/A. The applicable component
within the Department of Justice is the Drug Enforcement
Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public: Business or other for-profit.
Abstract: Pursuant to 21 U.S.C. 811(g)(3)(B), DEA (by delegation of
authority from the Attorney General) may, by regulation, exempt from
specific provisions of the Controlled Substances Act (CSA) any
compound, mixture, or preparation containing any controlled substance,
which is not for administration to a human being or animal, and which
is packaged in a certain manner, so that as packaged it does not
present any significant potential for abuse. In accordance with 21 CFR
1308.23(f), the Administrator (or the Deputy Assistant Administrator),
at any time, may revoke or modify any exemption granted pursuant to 21
CFR 1308.23; modify or revoke the criteria by which exemptions are
granted; and modify the scope of exemptions.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The below table
presents information regarding the number of respondents, responses and
associated burden hours.
----------------------------------------------------------------------------------------------------------------
Labor category Number % of time Cost
----------------------------------------------------------------------------------------------------------------
Chemist, GS-14, step 5.......................................... 3 30 $200,967
Unit Chief, GS-14, step 5....................................... 1 5 11,165
Section Chief, GS-15, step 5.................................... 1 1 2,627
-----------------------------------------------
Total....................................................... .............. .............. 214,758
----------------------------------------------------------------------------------------------------------------
6. An estimate of the total public burden (in hours) associated
with the proposed collection: DEA estimates that this collection takes
2,093 annual burden hours.
If additional information is required please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: April 21, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2021-08586 Filed 4-23-21; 8:45 am]
BILLING CODE 4410-09-P